Deep-pocketed investors have adopted a bearish approach towards Viking Therapeutics (NASDAQ:VKTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in VKTX usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 15 extraordinary options activities for Viking Therapeutics. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 26% leaning bullish and 66% bearish. Among these notable options, 3 are puts, totaling $99,420, and 12 are calls, amounting to $690,874.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $41.0 to $75.0 for Viking Therapeutics over the last 3 months.
Insights into Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Viking Therapeutics's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Viking Therapeutics's whale trades within a strike price range from $41.0 to $75.0 in the last 30 days.
Viking Therapeutics 30-Day Option Volume & Interest Snapshot
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BEARISH | 01/16/26 | $19.1 | $16.0 | $16.0 | $75.00 | $240.0K | 358 | 5 |
| VKTX | CALL | SWEEP | BEARISH | 08/16/24 | $5.6 | $5.5 | $5.5 | $65.00 | $76.4K | 699 | 20 |
| VKTX | CALL | SWEEP | BEARISH | 09/20/24 | $5.9 | $5.7 | $5.7 | $70.00 | $47.3K | 1.8K | 506 |
| VKTX | CALL | SWEEP | BEARISH | 09/20/24 | $5.7 | $5.7 | $5.7 | $70.00 | $47.3K | 1.8K | 356 |
| VKTX | CALL | SWEEP | BEARISH | 09/20/24 | $5.8 | $5.7 | $5.7 | $70.00 | $47.3K | 1.8K | 256 |
About Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Having examined the options trading patterns of Viking Therapeutics, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Viking Therapeutics's Current Market Status
- With a trading volume of 818,180, the price of VKTX is up by 1.42%, reaching $53.48.
- Current RSI values indicate that the stock is may be oversold.
- Next earnings report is scheduled for 42 days from now.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Viking Therapeutics with Benzinga Pro for real-time alerts.